Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06440421Not ApplicableCompleted

Understanding Food Choices in Bahrain Using Bahrain e-Mart

Role: collaborator

NCT06069258Recruiting

Movement Behaviours Among Bahraini Diabetics

Role: collaborator

NCT04827966Not ApplicableTerminated

Remineralization Agents for the Treatment of White Spot Lesions

Role: lead

NCT04993560Completed

Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain

Role: collaborator

NCT04390815Phase 4Unknown

Effect of Insulin on Wound Healing-A Randomized Controlled Trial

Role: lead

All 5 trials loaded